Literature DB >> 10563494

Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains.

D C Rogers1, D N Jones, P R Nelson, C M Jones, C A Quilter, T L Robinson, J J Hagan.   

Abstract

Detailed characterisation of six inbred strains of mice commonly used in transgenic and knockout research was carried out using a battery of behavioural tests (SHIRPA) followed by discriminant analysis of the data. In the primary observation screen, DBA/2 mice were relatively irritable and vocalised during handling. C57BL/6 were hyperactive as measured by transfer arousal, arena activity and touch-escape tests. By contrast, C3H were markedly hypoactive, had significantly enhanced grip strength and were also significantly impaired on the visual placing task. In the elevated plus-maze, BALB/c mice showed the highest level of open arm entries and time spent in the open arms, indicating the lowest level of anxiety. There was a clear dissociation of strains on exploratory activity, as measured in the holeboard test and spontaneous locomotor activity (LMA). DBA/2 mice were hyperactive in LMA but demonstrated relatively low levels of holeboard exploration. None of the six strains learnt the water maze spatial learning task particularly well. C57BL/6 and 129/Sv demonstrated most ability and C3H showed no evidence of having acquired the task. The SHIRPA screening battery and discriminant analysis of the data have enabled us to determine the relevant contribution of a number of behavioural measurements to the marked differences in phenotype of mouse strains. These data confirm the importance of carrying out a comprehensive profile in order to accurately characterise the phenotype of gene-targeted and transgenic mice.

Entities:  

Mesh:

Year:  1999        PMID: 10563494     DOI: 10.1016/s0166-4328(99)00072-8

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  52 in total

1.  Measuring anxiety- and locomotion-related behaviours in mice: a new way of using old tests.

Authors:  Leanne M Fraser; Richard E Brown; Ahmed Hussin; Mara Fontana; Ashley Whittaker; Timothy P O'Leary; Lauren Lederle; Andrew Holmes; André Ramos
Journal:  Psychopharmacology (Berl)       Date:  2010-05-08       Impact factor: 4.530

2.  Genetic background modulates behavioral impairments in R6/2 mice and suggests a role for dominant genetic modifiers in Huntington’s disease pathogenesis.

Authors:  Randi-Michelle Cowin; Nghiem Bui; Deanna Graham; Jennie R Green; Lisa A Yuva-Paylor; Andreas Weiss; Richard Paylor
Journal:  Mamm Genome       Date:  2012-06       Impact factor: 2.957

3.  Changes in behaviors of male C57BL/6J mice across adult life span and effects of dietary restriction.

Authors:  Andreas Fahlström; Hugo Zeberg; Brun Ulfhake
Journal:  Age (Dordr)       Date:  2011-10-12

4.  Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains.

Authors:  Sheryl S Moy; Jessica J Nadler; Nancy B Young; Antonio Perez; L Paige Holloway; Ryan P Barbaro; Justin R Barbaro; Lindsay M Wilson; David W Threadgill; Jean M Lauder; Terry R Magnuson; Jacqueline N Crawley
Journal:  Behav Brain Res       Date:  2006-09-12       Impact factor: 3.332

5.  Genotype-environment interactions in mouse behavior: a way out of the problem.

Authors:  Neri Kafkafi; Yoav Benjamini; Anat Sakov; Greg I Elmer; Ilan Golani
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-11       Impact factor: 11.205

6.  Implementation of the modified-SHIRPA protocol for screening of dominant phenotypes in a large-scale ENU mutagenesis program.

Authors:  Hiroshi Masuya; Maki Inoue; Yumiko Wada; Aya Shimizu; Junko Nagano; Akiko Kawai; Ayako Inoue; Tomoko Kagami; Taeko Hirayama; Ayako Yamaga; Hideki Kaneda; Kimio Kobayashi; Osamu Minowa; Ikuo Miura; Yoichi Gondo; Tetsuo Noda; Shigeharu Wakana; Toshihiko Shiroishi
Journal:  Mamm Genome       Date:  2005-11-11       Impact factor: 2.957

Review 7.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

Review 8.  Translating therapies for Huntington's disease from genetic animal models to clinical trials.

Authors:  Steven M Hersch; Robert J Ferrante
Journal:  NeuroRx       Date:  2004-07

9.  Effects of buprenorphine and meloxicam analgesia on induced cerebral ischemia in C57BL/6 male mice.

Authors:  Kirsten R Jacobsen; Natasha Fauerby; Zindy Raida; Otto Kalliokoski; Jann Hau; Flemming F Johansen; Klas Sp Abelson
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

10.  Neurodevelopmental impairment following neonatal hyperoxia in the mouse.

Authors:  Manimaran Ramani; Thomas van Groen; Inga Kadish; Arlene Bulger; Namasivayam Ambalavanan
Journal:  Neurobiol Dis       Date:  2012-10-12       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.